Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy

JAMA Oncol. 2018 Jul 1;4(7):994-996. doi: 10.1001/jamaoncol.2018.0977.

Inmaculada Hernandez^{1

2}, Vinay Prasad^{3

4

5}, Walid F Gellad^{2

6}

¹ Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
² Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania.
³ Division of Hematology Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland.
⁴ Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland.
⁵ Center for Health Care Ethics, Oregon Health & Science University, Portland.
⁶ Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Abstract

This study estimates the total costs associated with administering chimeric antigen receptor T-cell treatment.